Evidence map›Paper›PMID 35976525›Full record

ArticlePrevention science : the official journal of the Society for Prevention Research2023

Methodological Strategies for Prospective Harmonization of Studies: Application to 10 Distinct Outcomes Studies of Preventive Interventions Targeting Opioid Misuse.

Ty A Ridenour, Gracelyn Cruden, Yang Yang, Erin E Bonar, Anthony Rodriguez, Lissette M Saavedra, Andrea M Hussong, Maureen A Walton, Bethany Deeds, Jodi L Ford and 11 more

Open access · greenAbstract read
In one paragraph

Article in Prevention science : the official journal of the Society for Prevention Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Advancing Science to Prevent Firearm Violence in Communities: A Process for Harmonizing Studies to Develop Research Infrastructure.Prevention science : the official journal of the Society for Prevention Research · 2024
    Article
  7. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024
    Review
  8. Article
  9. Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
  10. Article
  11. Article
  12. Economic Evaluation Design within the HEAL Prevention Cooperative.Prevention science : the official journal of the Society for Prevention Research · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 13 institutions in 1 country.

Ty A RidenourRTI International, 3040 E. Cornwallis Rd., PO Box 12194, 326 Cox Bldg, Research Triangle Park, 27709-2194, NC, USA. tridenour@rti.org.ORCID 0000-0002-9709-6808
Gracelyn CrudenOregon Social Learning Center, Eugene, USA.
Yang YangTexas Christian University, Fort Worth, USA.
Erin E BonarUniversity of Michigan, Ann Arbor, USA.
Anthony RodriguezRAND Corporation, & University of California, Los Angeles, USA.
Lissette M SaavedraRTI International, 3040 E. Cornwallis Rd., PO Box 12194, 326 Cox Bldg, Research Triangle Park, 27709-2194, NC, USA.
Andrea M HussongUniversity of North Carolina, Chapel Hill, USA.
Maureen A WaltonUniversity of Michigan, Ann Arbor, USA.
Bethany DeedsNational Institute On Drug Abuse, North Bethesda, USA.
Jodi L FordThe Ohio State University, Columbus, USA.
Danica K KnightTexas Christian University, Fort Worth, USA.
Kevin P HaggertySeattle Children's Hospital & University of Washington, Seattle, USA.
Elizabeth StormshakUniversity of Oregon, Eugene, USA.
Terrence K KominskyEmory University and the Cherokee Nation, Atlanta, USA.
Kym R AhrensSeattle Children's Hospital & University of Washington, Seattle, USA.
Diana WoodwardMassachusetts General Hospital, Boston, USA.
Xin FengThe Ohio State University, Columbus, USA.
Lynn E FiellinYale University, New Haven, USA.
Timothy E WilensMassachusetts General Hospital, Boston, USA.
David J KleinRAND Corporation, & University of California, Los Angeles, USA.
Claudia-Santi FernandesYale University, New Haven, USA.
Massachusetts General Hospital · USRAND Corporation · USRTI International · USSeattle Children's Hospital · USTexas Christian University · USThe Ohio State University · USUniversity of Michigan · USYale University · USEmory University · USNational Institute on Drug Abuse · USOregon Social Learning Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Oregon · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Supplement to Prevention Research Center: Parenting Among Women Who Are Opioid Users, Project 2P50DA048756 · NIDA · UNIVERSITY OF OREGON · PI FISHER, PHILIP A, LEVE, LESLIE DIANE · 2019 to 2023
$18.0M
Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young AdultsU24DA050182 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI GRAHAM, PHILLIP W · 2019 to 2025
$11.6M
Supplement to HOME Trial: Role of Justice Involvement in Implementation and Effectiveness of Housing First for Youth Experiencing HomelessnessUH3DA050174 · NIDA · OHIO STATE UNIVERSITY · PI KELLEHER, KELLY J, SLESNICK, NATASHA · 2020 to 2023
$6.0M
Optimized Interventions to Prevent Opioid Use Disorder among Adolescents and Young Adults in the Emergency DepartmentUH3DA050173 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BONAR, ERIN E., WALTON, MAUREEN A · 2020 to 2021
$5.8M
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in CaliforniaUH3DA050235 · NIDA · RAND CORPORATION · PI D'AMICO, ELIZABETH J., DICKERSON, DANIEL LEE · 2020 to 2023
$5.3M
Preventing Parental Opioid and/or Methamphetamine Addiction within DHS-Involved Families: FAIRUH3DA050193 · NIDA · OREGON SOCIAL LEARNING CENTER, INC. · PI SALDANA, LISA · 2020 to 2020
$5.1M
Community Randomized Trial in the Cherokee Nation: CONNECT and CMCA for Preventing Drug Misuse among Older AdolescentsUH3DA050234 · NIDA · EMORY UNIVERSITY · PI KOMRO, KELLI ANN, LIVINGSTON, MELVIN D · 2020 to 2023
$4.9M
Preventing Opioid Use Among Justice-Involved Youth as They Transition to Adulthood: Leveraging Safe Adults (LeSA)UH3DA050250 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, DANICA K · 2020 to 2020
$4.5M
The Role of Family Functioning and Race/Ethnicity on the Efficacy of an Opioid Misuse Prevention Videogame Intervention for AdolescentsUH3DA050251 · NIDA · YALE UNIVERSITY · PI FIELLIN, LYNN ELIZABETH · 2021 to 2021
$4.4M
Using SMART Design to Identify an Effective and Cost-Beneficial Approach to Preventing OUD in Justice-Involved YouthUH3DA050189 · NIDA · SEATTLE CHILDREN'S HOSPITAL · PI AHRENS, KYM R, HAGGERTY, KEVIN P · 2021 to 2023
$4.1M
NCATS NIH HHS KL2 TR001862NCATS NIH HHS UL1 TR001863NCIPC CDC HHS U01 CE003482NIDA NIH HHS P50 DA048756NIDA NIH HHS P50DA048756NIDA NIH HHS U24 DA050182NIDA NIH HHS U24DA050182NIDA NIH HHS UG3 DA050189NIDA NIH HHS UG3DA050189NIDA NIH HHS UG3 DA050234NIDA NIH HHS UG3DA050251NIDA NIH HHS UH3 DA050173NIDA NIH HHS UH3DA050173NIDA NIH HHS UH3 DA050174NIDA NIH HHS UH3DA050174NIDA NIH HHS UH3 DA050189NIDA NIH HHS UH3 DA050193NIDA NIH HHS UH3DA050193NIDA NIH HHS UH3 DA050234NIDA NIH HHS UH3DA050234NIDA NIH HHS UH3 DA050235NIDA NIH HHS UH3DA050235NIDA NIH HHS UH3 DA050250NIDA NIH HHS UH3DA050250NIDA NIH HHS UH3 DA050251NIDA NIH HHS UH3 DA050252NIDA NIH HHS UH3DA050252
6 · The paper itself

Abstract

The Helping to End Addiction Long-Term (HEAL) Prevention Cooperative (HPC) is rapidly developing 10 distinct evidence-based interventions for implementation in a variety of settings to prevent opioid misuse and opioid use disorder. One HPC objective is to compare intervention impacts on opioid misuse initiation, escalation, severity, and disorder and identify whether any HPC interventions are more effective than others for types of individuals. It provides a rare opportunity to prospectively harmonize measures across distinct outcomes studies. This paper describes the needs, opportunities, strategies, and processes that were used to harmonize HPC data. They are illustrated with a strategy to measure opioid use that spans the spectrum of opioid use experiences (termed involvement) and is composed of common "anchor items" ranging from initiation to symptoms of opioid use disorder. The limitations and opportunities anticipated from this approach to data harmonization are reviewed. Lastly, implications for future research cooperatives and the broader HEAL data ecosystem are discussed.

Indexed as

Analgesics, OpioidOpioid-Related DisordersCognitionEcosystemHumansProspective StudiesAnalgesics, OpioidAdolescentsHarmonizationIntegrative data analysisOpioid misuseOpioid use disorderPreventionYoung adults

Identifiers

PMID35976525
PMCPMC9935745
OpenAlexW4292263362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.